krro-110
·Code: KRRO-110
krro-110: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Korro Bio, Inc. (KRRO) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2a, Single- and Multiple-dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KRRO 110 in Healthy Adult Volunteers and in Adult Participants With Alpha-1 Antitrypsin Deficiency (AATD) (REWRITE)
Frequently asked questions
Who is developing krro-110?
krro-110 is being developed by Korro Bio, Inc..
How many clinical trials involve krro-110?
BioSniper tracks 1 clinical trial involving krro-110.
Get deeper analysis on krro-110
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis